Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Hemorrhagic Septicemia (Fish) Vaccine is a veterinary aquatic health product currently under development by Indian Immunologicals. It is designed to provide protective immunity against the pathogens responsible for hemorrhagic septicemia in fish populations, a severe systemic condition characterized by internal and external bleeding and high mortality rates in aquaculture. The vaccine is intended to stimulate the fish's immune system to recognize and combat causative agents, which can include bacterial pathogens such as *Aeromonas hydrophila* or viral agents like the Viral Hemorrhagic Septicemia Virus (VHSV). According to company pipeline information, the vaccine is in an advanced stage of development and aims to mitigate the significant economic impact of this disease in the fisheries sector.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hemorrhagic Septicemia (Fish) Vaccine.